US 510(k) clearance for Kensey Nash's QuickCat extraction catheter:
This article was originally published in Clinica
Endovascular device specialist Kensey Nash has received FDA 510(k) approval for the sale of its QuickCat extraction catheter, used for the removal of blood clots from arterial blood vessels. The Exton, Pennsylvania firm claims the product is easy to use, and provides reliable clot removal. The QuickCat will be a complementary offering to the firm's ThromCat system, used for more complex clots, which is currently under regulatory review in the US and Europe. The thrombectomy catheter systems market is estimated to be worth $100m worldwide, including the coronary market.